Developing regions vs Guyana: Proportion of the target population … measles-containing-vaccine
Developing regions
75.0%
in 2024
Guyana
97.0%
in 2024
Developing regions rank
23rd
Guyana rank
22nd
Proportion of the target population … measles-containing-vaccine over time
- Developing regions
- Guyana
How they compare
Guyana currently reports 97.0% against 75.0% in Developing regions, a difference of 22.0%.
That makes Guyana's figure about 1.3 times Developing regions's.
Across all 24 years both countries report, Guyana has been ahead every year.
Developing regions ranks 23rd and Guyana ranks 22nd of 36 groups.
Guyana has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Developing regions | Guyana | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.3% | 78.4% | 54.1% | Guyana |
| 2010s | 56.0% | 90.0% | 34.0% | Guyana |
| 2020s | 71.0% | 95.0% | 24.0% | Guyana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received, Developing regions or Guyana?
- Guyana, at 97.0% against 75.0% in Developing regions as of 2024.
- What is the difference in proportion of the target population who received between Developing regions and Guyana?
- 22.0%, with Guyana ahead.
- How many years of comparable data are there for Developing regions and Guyana?
- 24 years are reported by both, from 2001 to 2024.
- How do Developing regions and Guyana rank globally for proportion of the target population who received?
- Developing regions ranks 23rd and Guyana ranks 22nd of 36 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received measles-containing-vaccine second-dose (MCV2) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.